Clinical Trials Directory

Trials / Unknown

UnknownNCT01034319

Genetic Counseling and Lifestyle Change for Diabetes Prevention

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Controls will not be tested. All subjects will be enrolled in a 12-week diabetes prevention program.

Detailed description

This study will examine the impact diabetes genetic counseling on patient motivation and disease prevention behaviors among subjects with pre-diabetes. We will randomize subjects with pre-diabetes to genetic testing vs. no genetic testing in order to obtain an unconfounded test of the hypothesis that genetic testing will change patient behavior. Intervention subjects will be provided with their individual diabetes genotype risk score derived from aggregating the combined results of 37 diabetes risk-associated genetic loci. Because patients can receive either "Higher risk" or "Lower risk" genetic test results, we will separately examine the impact of "Higher risk" and "Lower risk" test results compared to untested controls. All subjects will be enrolled in a 12-week diabetes prevention program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDiabetes Genetic CounselingSubjects will be genotyped based on a 37-allele aggregate score and counseled regarding the implications of the results prior to enrollment in a 12-week diabetes prevention program
BEHAVIORALNo genetic counselingThese subjects will not be genotyped or counseled prior to enrollment in a 12-week diabetes prevention program

Timeline

Start date
2009-12-01
Primary completion
2011-08-01
Completion
2012-12-01
First posted
2009-12-17
Last updated
2011-07-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01034319. Inclusion in this directory is not an endorsement.